These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 20797373)

  • 1. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
    Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV
    J Clin Psychiatry; 2010 Aug; 71(8):e1-e21. PubMed ID: 20797373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
    Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV
    J Clin Psychiatry; 2010 Aug; 71(8):1040-6. PubMed ID: 20673551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
    Posner K; Oquendo MA; Gould M; Stanley B; Davies M
    Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
    Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus Meeting.
    Chappell PB; Stewart M; Alphs L; DiCesare F; DuBrava S; Harkavy-Friedman J; Lim P; Ratcliffe S; Silverman MM; Targum SD; Marder SR
    J Clin Psychiatry; 2017 Jun; 78(6):e638-e647. PubMed ID: 28682533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.
    Stone M; Laughren T; Jones ML; Levenson M; Holland PC; Hughes A; Hammad TA; Temple R; Rochester G
    BMJ; 2009 Aug; 339():b2880. PubMed ID: 19671933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA; Laughren T; Racoosin J
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
    Akiskal HS; Benazzi F
    J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents.
    Bridge JA; Axelson DA
    Int Rev Psychiatry; 2008 Apr; 20(2):209-14. PubMed ID: 18386214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal risk in antidepressant drug trials.
    Baldessarini RJ; Pompili M; Tondo L
    Arch Gen Psychiatry; 2006 Mar; 63(3):246-8. PubMed ID: 16520428
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.
    Niculescu AB; Levey DF; Phalen PL; Le-Niculescu H; Dainton HD; Jain N; Belanger E; James A; George S; Weber H; Graham DL; Schweitzer R; Ladd TB; Learman R; Niculescu EM; Vanipenta NP; Khan FN; Mullen J; Shankar G; Cook S; Humbert C; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR
    Mol Psychiatry; 2015 Nov; 20(11):1266-85. PubMed ID: 26283638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder.
    Thase ME; Gommoll C; Chen C; Kramer K; Khan A; Durgam S
    CNS Spectr; 2017 Dec; 22(6):475-483. PubMed ID: 28521846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Bauer MS; Wisniewski SR; Marangell LB; Chessick CA; Allen MH; Dennehy EB; Miklowitz DJ; Thase ME; Sachs GS
    J Clin Psychiatry; 2006 Jan; 67(1):48-55. PubMed ID: 16426088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment.
    Levey DF; Niculescu EM; Le-Niculescu H; Dainton HL; Phalen PL; Ladd TB; Weber H; Belanger E; Graham DL; Khan FN; Vanipenta NP; Stage EC; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR; Niculescu AB
    Mol Psychiatry; 2016 Jun; 21(6):768-85. PubMed ID: 27046645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials.
    Mahableshwarkar AR; Affinito J; Reines EH; Xu J; Nomikos G; Jacobsen PL
    CNS Spectr; 2020 Jun; 25(3):352-362. PubMed ID: 31199210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.